Expanding our knowledge of conditions associated with the ASXL gene family

Genome Medicine

Volumn 5, Issue 2, 2013, Pages

  Russell, Bianca ^a   Graham Jr , John M ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASXL GENE; ASXL1 GENE; ASXL2 GENE; ASXL3 GENE; BOHRING OPITZ SYNDROME; DROSOPHILA; GENE; GENE SEQUENCE; HUMAN; MEDULLOBLASTOMA; NONHUMAN; NONSENSE MUTATION; OPITZ SYNDROME; PHENOTYPE; PRIORITY JOURNAL; STOP CODON;

EID: 84874009428     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm420     Document Type: Article

References (10)

1. Bainbridge MN, Hao H, Muzny DM, Musante L, Lupski JR, Graham BH, Chen W, Gripp KW, Wienker TF, Yang Y, Sutton VR, Gibbs RA, Ropers HH. De novo truncating mutations in ASXL3 are associated with a novel clinical phenotype with similarities to Bohring-Opitz syndrome. Genome Med 2013, 5:11. 10.1186/gm415, 23383720.
2. Sinclair DA, Milne TA, Hodgson JW, Shellard J, Salinas CA, Kyba M, Randazzo F, Brock HW. The Additional sex combs gene of Drosophila encodes a chromatin protein that binds to shared and unique Polycomb group sites on polytene chromosomes. Development 1998, 125:1207-1216.
3. Katoh M, Katoh M. Identification and characterization of ASXL3 gene in silico. Int J Oncol 2004, 24:1617-1622.
4. Hoischen A, van Bon BWM, Rodriguez-Santiago B, Gilissen C, Vissers LE, de Vries P, Janssen I, van Lier B, Hastings R, Smithson SF, Newbury-Ecob R, Kjaergaard S, Goodship J, McGowan R, Bartholdi D, Rauch A, Peippo M, Cobben JM, Wieczorek D, Gillessen-Kaesbach G, Veltman JA, Brunner HG, de Vries BB. De novo nonsense mutations in ASXL1 cause Bohring-Opitz syndrome. Nat Genet 2011, 43:729-731. 10.1038/ng.868, 21706002.
5. Magini P, Monica MD, Uzielli MLG, Mongelli P, Scarselli G, Gambineri E, Scarano G, Seri M. Two novel patients with Bohring-Opitz syndrome caused by de novo ASXL1 mutations. Am J Med Genet A 2012, 158A:917-921. 10.1002/ajmg.a.35265, 22419483.
6. Boultwood J, Perry J, Pellagatti A, Fernandez-Mercado M, Fernandez-Santamaria C, Calasanz MJ, Larrayoz MJ, Garcia-Delgado M, Giagounidis A, Malcovati L, Della Porta MG, Jädersten M, Killick S, Hellström-Lindberg E, Cazzola M, Wainscoat JS. Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia. Leukemia 2010, 24:1062-1065. 10.1038/leu.2010.20, 20182461.
7. Kratz CP, Rapisuwon S, Reed H, Hasle H, Rosenberg PS. Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes. Am J Med Genet C Semin Med Genet 2011, 157:83-89. 10.1002/ajmg.c.30300, 3086183, 21500339.
8. Riviere J-B, Mirzaa GM, O'Roak BJ, Beddaoui M, Alcanrtara D, Conway RJ, St-Onge J, Worthylake T, Sullivan CT, Ward TR, Butler HE, Kramer NA, Albrecht B, Armour CM, Armstrong L, Caluferiu O, Cytrynbaum C, Drolet BA, Innes AM, Lauzon JL, Lin AE, Mancini GMS, Meschino WS, Reggin JD, Saggar AK, Lerman-Sagie T, Uyanik G, et al. De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes. Nat Genet 2012, 44:934-940. 10.1038/ng.2331, 3408813, 22729224.
9. Hastings RW, Newbury-Ecob R, Lunt PW. A case of probable Bohring-Opitz syndrome with medulloblastoma. Clin Dysmorphol 2010, 19:202-205. 10.1097/MCD.0b013e32833e07de, 20717007.
10. Brunner HG, van Tintelen JP, de Boer RJ. Bohring syndrome. Am J Med Genet 2000, 92:366-368. 10.1002/1096-8628(20000619)92:5<366::AID-AJMG15>3.0.CO;2-U, 10861670.